MicroRNA Signatures and Foxp3+ Cell Count Correlate With Relapse Occurrence in Follicular Lymphoma

Oncotarget - United States
doi 10.18632/oncotarget.24987
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Automated Prognostic Pattern Detection Shows Favourable Diffuse Pattern of FOXP3+ Tregs in Follicular Lymphoma

British Journal of Cancer
Cancer ResearchOncology
2015English

Follicular Large Cleaved Cell (Centrocytic) Lymphoma: A Distinctive but Unrecognized Variant of Follicular Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Predictive Value of Prima-Prognostic Index (Prima-Pi) in First Relapse of Follicular Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Follicular Lymphoma With Progression to Diffuse Large B-Cell Lymphoma and Concurrent CD5-Negative Mantle Cell Lymphoma-3 Entities in a Lymph Node

Cancer Control
MedicineOncologyHematology
2014English

Follicular Lymphoma

Nature Reviews Disease Primers
Medicine
2019English

Follicular Lymphoma-Like B Cells of Uncertain Significance (In Situ Follicular Lymphoma) May Infrequently Progress, but Precedes Follicular Lymphoma, Is Associated With Other Overt Lymphomas and Mimics Follicular Lymphoma in Flow Cytometric Studies

Haematologica
Hematology
2013English

Immunohistological Study in the Distribution and Function of Follicular Dendritic Cell(FDC) in Follicular Lymphoma.

Journal of the Japan Society of the Reticuloendothelial System
1990English

Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

Stem Cell Transplantation in Follicular Lymphoma: Progress at Last?

Bone Marrow Transplantation
TransplantationHematology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy